Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2025-12-25 @ 7:40 PM
NCT ID:
NCT04191135
Group ID:
EG000
Title:
Pembrolizumab + Carboplatin + Gemcitabine Induction Treatment
Description:
Participants receive both carboplatin Area Under The Curve (AUC) 2 with gemcitabine 1000 mg/m\^2 intravenously on Days 1 and 8 of each 21-day cycle plus pembrolizumab 200 mg intravenously on Day 1 of each 21-day cycle during the induction period for 4-6 cycles. Participants may then randomize to one of the blinded treatment arms.
Deaths Number Affected:
124
Deaths Number At Risk:
None
Serious Number Affected:
80
Serious Number At Risk:
460
Other Number Affected:
456
Other Number At Risk:
460
Study:
NCT04191135
Results Section:
NCT04191135
Adverse Events Module:
NCT04191135